IN8bio Reports Fourth Quarter and Full-Year 2025 Financial Results - Highlights Durable Survival Improvements in Glioblastoma, Advancing Pipeline and Strengthened Financial Position for 2026 [Yahoo! Finance]
IN8bio Reports Fourth Quarter and Full-Year 2025 Financial Results - Highlights Durable Survival Improvements in Glioblastoma, Advancing Pipeline and Strengthened Financial Position for 2026
IN8bio to Present at TD Cowen 46th Annual Health Care Conference
IN8bio promotes COO to president & COO [Seeking Alpha]
IN8bio Promotes Kate Rochlin, Ph.D., to President and Chief Operating Officer